Cocamide MEA

Cocamide MEA and pregnancy

Caution Advised

• Absorbed into the body
• Fetal development

Cocamide MEA is a surfactant used in cleansing products to create foam and improve texture. It's derived from coconut oil combined with monoethanolamine (MEA), and functions by helping water mix with oil and dirt for effective cleansing. The concern during pregnancy relates to potential nitrosamine contamination, which can occur when MEA-based ingredients degrade or interact with certain other cosmetic ingredients. Nitrosamines are classified as probable carcinogens, and while topical exposure is lower than oral exposure, some dermatologists recommend avoiding MEA-based surfactants during pregnancy due to theoretical risks. Additionally, ethanolamine compounds have shown developmental effects in animal studies at high doses, though human data is limited. While there are no official prohibitions from ACOG or the FDA specifically against cocamide MEA, the precautionary principle suggests that pregnant women may choose to avoid products containing MEA-based surfactants when alternative cleansers are available. Many pregnancy-safe product lines have reformulated to exclude these ingredients.

Cocamide MEA and breastfeeding

Caution Advised

• Passes into breast milk
• Infant exposure

Cocamide MEA is used in cleansing products like shampoos and body washes. As a rinse-off product ingredient, exposure is relatively brief, though some absorption through the skin can occur, particularly with damaged skin barriers or prolonged contact. The primary concern for breastfeeding relates to potential nitrosamine contamination and the fact that ethanolamine compounds are fat-soluble, meaning they could theoretically accumulate in breast tissue and transfer to milk. While specific studies on cocamide MEA transfer to breast milk don't exist, the precautionary approach suggests minimizing exposure to ingredients with carcinogenic contaminants during lactation. Many lactation consultants and dermatologists suggest that breastfeeding mothers choose products without MEA-based surfactants when alternatives are readily available. If using products containing cocamide MEA, ensure they are thoroughly rinsed off and avoid application near the breast area.

Cocamide MEA and postpartum

Safe to Use

• Irritant

For postpartum women who are not breastfeeding, cocamide MEA presents primarily cosmetic concerns rather than reproductive health risks. The ingredient may cause skin irritation, particularly on skin that is already sensitive from hormonal changes postpartum. While the nitrosamine contamination concern remains a general health consideration, the absence of breastfeeding removes the concern about infant exposure through milk. Women can use products containing this ingredient with awareness that it may cause irritation in some cases, but there are no specific postpartum contraindications beyond general skin sensitivity.

Cocamide MEA and trying to conceive

Caution Advised

• Builds up in tissue

While cocamide MEA is primarily a rinse-off ingredient with limited absorption, the theoretical concern about nitrosamine contamination applies to women trying to conceive. Some fertility specialists recommend minimizing exposure to potential carcinogens and endocrine disruptors during the preconception period. Because it can take several months to conceive and MEA-based compounds are fat-soluble, women trying to conceive may choose to switch to surfactants without MEA derivatives as a precautionary measure. This is particularly relevant for women using leave-on products or those with compromised skin barriers that may increase absorption.

Cocamide MEA and PCOS

Safe to Use

Cocamide MEA is a cleansing agent that does not interact with hormones or affect androgen levels. It has no known impact on PCOS symptoms, insulin sensitivity, or hormonal balance. Women with PCOS can use products containing cocamide MEA without concerns about hormonal interference. The primary consideration is skin tolerance, as PCOS-related skin changes may make individuals more prone to irritation from surfactants. There are no specific PCOS-related concerns with this ingredient. Women with PCOS who also have sensitive or acne-prone skin may prefer gentler surfactants, but this is based on skin type rather than the hormonal condition itself.

Cocamide MEA and general use

Caution Advised

• Irritant
• Carcinogen concern

Cocamide MEA is a widely used surfactant that helps cleansing products foam and perform effectively. It's been used in cosmetics for decades and remains legal in both the US and EU, though with increasing scrutiny. The main health concern is the potential for nitrosamine formation, which occurs when MEA-based ingredients are contaminated or react with certain other cosmetic ingredients. The International Agency for Research on Cancer (IARC) classifies nitrosamines as probable human carcinogens. While the risk from cosmetic exposure is considered lower than dietary exposure, some toxicologists recommend avoiding unnecessary exposure to nitrosamine-forming ingredients. The SCCS has recommended restricting nitrosamine contamination in cosmetics to very low levels. Modern manufacturing practices aim to minimize contamination, but consumers concerned about long-term exposure may choose products formulated with alternative surfactants like coco-glucoside or decyl glucoside, which don't have nitrosamine concerns.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive

Related ingredients

Cocamide MEA is itself suggested as the safer option on these pages.

• Palm Kernelamide Dea

Ingredients that raise the same concerns.

• MenadioneCarcinogen concern, Builds up in tissue, Fetal development
• P-PhenylenediamineCarcinogen concern, Builds up in tissue, Fetal development
• HydroquinoneCarcinogen concern, Builds up in tissue, Fetal development
• PhenolCarcinogen concern, Builds up in tissue, Fetal development
• DiethanolamineCarcinogen concern, Builds up in tissue, Fetal development
• 1-NaphtholCarcinogen concern, Builds up in tissue, Fetal development

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.